We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

1 results found


Dorsey & Whitney LLP | USA | 30 Mar 2011

FDA chemist charged for serial insider trading

FDA chemist Cheng Yi Liang was named as a defendant along with his son Andrew Liang in a criminal insider trading complaint.

Previous page 1 Next page